Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions

NACompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Laparoscopic Surgery
Interventions
DEVICE

LiquiBand Laparoscopic

LiquiBand Laparoscopic™ is a sterile, liquid adhesive made up of a blend of n-butyl and 2-octyl cyanoacrylate intended for soft tissue approximation of skin wounds. It is packaged in a sterile, single-use, nylon applicator with internal glass ampoule containing 0.8g of adhesive and sealed in a PETG/Tyvek blister pack. LiquiBand Laparoscopic™ is intended to be applied topically to pre-apposed wound edges. The tissue adhesive sets rapidly (5 - 10 seconds) to hold the wound closed. Following wound closure the product is designed to apply a broad coverage of adhesive to act as a liquid dressing to protect the wound.

DEVICE

Dermabond

High viscosity DermaBond Topical Skin Adhesive is a sterile, liquid topical skin adhesive containing a monomeric (2-octyl cyanoacrylate) formulation and the colorant D \& C Violet #2. It is provided in a single use applicator packaged in a blister pouch. The applicator is comprised of a crushable glass ampule contained within a plastic vial with attached applicator tip. As applied to skin, the liquid is syrup-like in viscosity and polymerizes within minutes.

Trial Locations (4)

MK6 5LD

Milton Keynes General Hospital, Milton Keynes

EX2 5DW

Royal Devon and Exeter Hospital (Wonford, Exeter

GU2 7XX

Royal Surrey County Hospital, Guildford

HD3 3FA

Huddesfield Royal Infirmary, Huddersfield

All Listed Sponsors
lead

MedLogic Global Limited

INDUSTRY

NCT00762905 - Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions | Biotech Hunter | Biotech Hunter